Endothelial and Platelet Microparticles in Vasculitis of the Young

Arthritis and Rheumatism

Volumn 50, Issue 3, 2004, Pages 927-936

  Brogan, P A ^a   Shah, V ^a   Brachet, C ^a   Harnden, A ^b   Mant, D ^b   Klein, N ^a   Dillon, M J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD42A ANTIGEN; CELL PROTEIN; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FEMALE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOTHESIS; INFANT; MALE; PLASMA; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC VASCULITIS; THROMBOCYTE; ULTRACENTRIFUGATION; VASCULITIS;

EID: 1542411587     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20199     Document Type: Article

References (36)

1. Brogan PA, Dillon MJ. Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2000;2:411-6.
2. Sundy JS, Haynes BF. Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr Rheumatol Rep 2000;2:402-10.
3. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-32.
4. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999;99:348-53.
5. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000;101:841-3.
6. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102.
7. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001;112:81-90.
8. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001;56:1319-24.
9. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-46.
10. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85:810-20.
11. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95:930-5.
12. Larkin M. Raised endothelial microparticles: an early marker for multiple sclerosis? Lancet 2001;357:1679.
13. Woywodt A, Streiber F, deGroot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003;361:206-10.
14. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003;131:536-40.
15. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
16. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score in systemic necrotizing vasculitis. QJM 1994;87:671-8.
17. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80.
18. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
19. Combes V, Dignat-George F, Mutin M, Sampol J. A new flow cytometry method of platelet-derived microvesicle quantitation in plasma. Thromb Haemost 1997;77:220.
20. Gilbert R, Logan S. Assessing diagnostic and screening tests. In: Moyer VA, Elliot EJ, Davis RL, Gilbert R, Klassen T, Logan S, et al, editors. Evidence based pediatrics and child health. London: BMJ Books; 2000. p. 24-36.
21. Brogan PA, Davies R, Gordon I, Dillon MJ. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 2002;17:277-83.
22. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. CD105. In: Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA, editors. The leucocyte antigen facts book. San Diego: Academic Press, Harcourt Brace and Company; 1997. p. 384-5.
23. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. CD62E. In: Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA, editors. The leucocyte antigen facts book. San Diego: Academic Press, Harcourt Brace and Company; 1997. p. 295-7.
24. Harashima S, Horiuchi T, Hatta N, Morita C, Higuchi M, Sawabe T, et al. Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol 2001;166:130-6.
25. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. CD54. In: Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA, editors. The leucocyte antigen facts book. San Diego: Academic Press, Harcourt Brace and Company; 1997. p. 278-9.
26. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. CD106. In: Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA, editors. The leucocyte antigen facts book. San Diego: Academic Press, Harcourt Brace and Company; 1997. p. 386-7.
27. Nash MC, Shah V, Dillon MJ. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol 1995;101:13-7.
28. Malhotra R, Taylor NR, Bird MI. Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site. Biochem J 1996;314:297-303.
29. Brogan PA, Dillon MJ. The use of immunosuppressive and cytotoxic drugs in non-malignant disease. Arch Dis Child 2000;83:259-64.
30. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001;88:998-1003.
31. Tedgui A, Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemost 2001;86:420-6.
32. Brogan PA, Shah V, Bagga A, Klein N, Dillon MJ. T cell Vβ repertoires in childhood vasculitides. Clin Exp Immunol 2003;131:517-27.
33. Leavitt RY, Fauci AS. Polyangiitis overlap syndrome. Am J Med 1986;81:79-85.
34. Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M. Pathological haemostasis and "prothrombotic state" in Behcet's disease. Thromb Res 2002;105:125-33.
35. Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun 1993;6:237-49.
36. Jimenez JJ, Wenche J, Mauro LM, Soderland C, Horstman LL, Ahn Y. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-80.